Annual Report 2020

CONSOLIDATED STATEMENT OF CASH FLOWS For the year ended 31 December 2020 45 The United Laboratories International Holdings Limited Annual Report 2020 2020 2019 RMB’000 RMB’000 Investing activities Payments for purchase of property, plant and equipment (514,980) (374,977) Payment for deposits of acquisition of property, plant and equipment (15,775) (56,426) Payments for right-of-use assets – (9,056) Proceeds on disposal of property, plant and equipment 61,500 7,380 Placement of pledged bank deposits (1,735,053) (3,268,497) Withdrawal of pledged bank deposits 2,019,912 3,099,195 Placement of other pledged deposits – (31,423) Withdrawal of other pledged deposits 7,423 46,737 Interest received 41,093 51,156 Receipts of government grants 9,454 11,111 Receipt of consideration receivables 300,000 100,000 Additions to intangible assets (6,815) (8,447) Net cash from (used in) investing activities 166,759 (433,247) Financing activities Interest paid (124,156) (215,754) Dividends paid (128,140) (98,383) Repayment of lease liabilities (1,641) (114,991) New borrowings raised 2,406,098 3,732,147 Repayment of borrowings (4,061,196) (2,985,288) Net cash (used in) from financing activities (1,909,035) 317,731 Net (decrease) increase in cash and cash equivalents (173,014) 1,685,668 Effect of foreign exchange rate changes 4,997 (2,745) Cash and cash equivalents at beginning of the year 3,164,819 1,481,896 Cash and cash equivalents at end of the year 2,996,802 3,164,819